Cargando…

In vivo Ebola virus infection leads to a strong innate response in circulating immune cells

BACKGROUND: Ebola virus is the causative agent of a severe syndrome in humans with a fatality rate that can approach 90 %. During infection, the host immune response is thought to become dysregulated, but the mechanisms through which this happens are not entirely understood. In this study, we analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Caballero, Ignacio S., Honko, Anna N., Gire, Stephen K., Winnicki, Sarah M., Melé, Marta, Gerhardinger, Chiara, Lin, Aaron E., Rinn, John L., Sabeti, Pardis C., Hensley, Lisa E., Connor, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011782/
https://www.ncbi.nlm.nih.gov/pubmed/27595844
http://dx.doi.org/10.1186/s12864-016-3060-0
_version_ 1782451892461240320
author Caballero, Ignacio S.
Honko, Anna N.
Gire, Stephen K.
Winnicki, Sarah M.
Melé, Marta
Gerhardinger, Chiara
Lin, Aaron E.
Rinn, John L.
Sabeti, Pardis C.
Hensley, Lisa E.
Connor, John H.
author_facet Caballero, Ignacio S.
Honko, Anna N.
Gire, Stephen K.
Winnicki, Sarah M.
Melé, Marta
Gerhardinger, Chiara
Lin, Aaron E.
Rinn, John L.
Sabeti, Pardis C.
Hensley, Lisa E.
Connor, John H.
author_sort Caballero, Ignacio S.
collection PubMed
description BACKGROUND: Ebola virus is the causative agent of a severe syndrome in humans with a fatality rate that can approach 90 %. During infection, the host immune response is thought to become dysregulated, but the mechanisms through which this happens are not entirely understood. In this study, we analyze RNA sequencing data to determine the host response to Ebola virus infection in circulating immune cells. RESULTS: Approximately half of the 100 genes with the strongest early increases in expression were interferon-stimulated genes, such as ISG15, OAS1, IFIT2, HERC5, MX1 and DHX58. Other highly upregulated genes included cytokines CXCL11, CCL7, IL2RA, IL2R1, IL15RA, and CSF2RB, which have not been previously reported to change during Ebola virus infection. Comparing this response in two different models of exposure (intramuscular and aerosol) revealed a similar signature of infection. The strong innate response in the aerosol model was seen not only in circulating cells, but also in primary and secondary target tissues. Conversely, the innate immune response of vaccinated macaques was almost non-existent. This suggests that the innate response is a major aspect of the cellular response to Ebola virus infection in multiple tissues. CONCLUSIONS: Ebola virus causes a severe infection in humans that is associated with high mortality. The host immune response to virus infection is thought to be an important aspect leading to severe pathology, but the components of this overactive response are not well characterized. Here, we analyzed how circulating immune cells respond to the virus and found that there is a strong innate response dependent on active virus replication. This finding is in stark contrast to in vitro evidence showing a suppression of innate immune signaling, and it suggests that the strong innate response we observe in infected animals may be an important contributor to pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-016-3060-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5011782
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50117822016-09-07 In vivo Ebola virus infection leads to a strong innate response in circulating immune cells Caballero, Ignacio S. Honko, Anna N. Gire, Stephen K. Winnicki, Sarah M. Melé, Marta Gerhardinger, Chiara Lin, Aaron E. Rinn, John L. Sabeti, Pardis C. Hensley, Lisa E. Connor, John H. BMC Genomics Research Article BACKGROUND: Ebola virus is the causative agent of a severe syndrome in humans with a fatality rate that can approach 90 %. During infection, the host immune response is thought to become dysregulated, but the mechanisms through which this happens are not entirely understood. In this study, we analyze RNA sequencing data to determine the host response to Ebola virus infection in circulating immune cells. RESULTS: Approximately half of the 100 genes with the strongest early increases in expression were interferon-stimulated genes, such as ISG15, OAS1, IFIT2, HERC5, MX1 and DHX58. Other highly upregulated genes included cytokines CXCL11, CCL7, IL2RA, IL2R1, IL15RA, and CSF2RB, which have not been previously reported to change during Ebola virus infection. Comparing this response in two different models of exposure (intramuscular and aerosol) revealed a similar signature of infection. The strong innate response in the aerosol model was seen not only in circulating cells, but also in primary and secondary target tissues. Conversely, the innate immune response of vaccinated macaques was almost non-existent. This suggests that the innate response is a major aspect of the cellular response to Ebola virus infection in multiple tissues. CONCLUSIONS: Ebola virus causes a severe infection in humans that is associated with high mortality. The host immune response to virus infection is thought to be an important aspect leading to severe pathology, but the components of this overactive response are not well characterized. Here, we analyzed how circulating immune cells respond to the virus and found that there is a strong innate response dependent on active virus replication. This finding is in stark contrast to in vitro evidence showing a suppression of innate immune signaling, and it suggests that the strong innate response we observe in infected animals may be an important contributor to pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-016-3060-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-09-05 /pmc/articles/PMC5011782/ /pubmed/27595844 http://dx.doi.org/10.1186/s12864-016-3060-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Caballero, Ignacio S.
Honko, Anna N.
Gire, Stephen K.
Winnicki, Sarah M.
Melé, Marta
Gerhardinger, Chiara
Lin, Aaron E.
Rinn, John L.
Sabeti, Pardis C.
Hensley, Lisa E.
Connor, John H.
In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
title In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
title_full In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
title_fullStr In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
title_full_unstemmed In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
title_short In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
title_sort in vivo ebola virus infection leads to a strong innate response in circulating immune cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011782/
https://www.ncbi.nlm.nih.gov/pubmed/27595844
http://dx.doi.org/10.1186/s12864-016-3060-0
work_keys_str_mv AT caballeroignacios invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells
AT honkoannan invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells
AT girestephenk invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells
AT winnickisarahm invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells
AT melemarta invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells
AT gerhardingerchiara invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells
AT linaarone invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells
AT rinnjohnl invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells
AT sabetipardisc invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells
AT hensleylisae invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells
AT connorjohnh invivoebolavirusinfectionleadstoastronginnateresponseincirculatingimmunecells